BIoEclipse Therapeutics Competitors and Similar CompaniesClear all

Zymeworks's competitors and similar companies include Coherus Oncology, Neovii and ImmPACT-Bio.

	Zymeworks Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.	Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.	Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.	ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
Founding Date	Founding Date 2003	Founding Date 2010	Founding Date 2003	Founding Date 2017
Type	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy	Tags Healthcare biotech oncology therapy
Locations	Locations Vancouver, CA HQ Seattle, US	Locations Redwood City, US HQ Camarillo, US	Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US	Locations Camarillo, US HQ Rishon Le Tsiyon, IL
Employees	Employees 45519% increase	Employees 14736% decrease	Employees 1193% increase	Employees 845% decrease
Valuation ($)	Valuation ($) 973.3 m	Valuation ($) 85.6 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $106m (FY, 2025)	Revenue (est.) $42.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($81.1m) (FY, 2025)	Net income $168m (FY, 2025)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 125.9m	Total funding raised $ 174.5m	Total funding raised N/A	Total funding raised $ 18m